These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
397 related articles for article (PubMed ID: 3923100)
1. Differential effects of recombinant human interferon-gamma and interleukin 2 on natural killer cell activity of peripheral blood in early human development. Ueno Y; Miyawaki T; Seki H; Matsuda A; Taga K; Sato H; Taniguchi N J Immunol; 1985 Jul; 135(1):180-4. PubMed ID: 3923100 [TBL] [Abstract][Full Text] [Related]
2. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism. Rook AH; Hooks JJ; Quinnan GV; Lane HC; Manischewitz JF; Macher AM; Masur H; Fauci AS; Djeu JY J Immunol; 1985 Mar; 134(3):1503-7. PubMed ID: 3918102 [TBL] [Abstract][Full Text] [Related]
3. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects. Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980 [TBL] [Abstract][Full Text] [Related]
4. Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma). Itoh K; Shiiba K; Shimizu Y; Suzuki R; Kumagai K J Immunol; 1985 May; 134(5):3124-9. PubMed ID: 2984283 [TBL] [Abstract][Full Text] [Related]
5. Immunomodulating effects in vitro of interleukin-2 and interferon-gamma on human blood and bone marrow mononuclear cells. Kedar E; Rezai AR; Giorgi JV; Gale RP; Champlin RE; Mitsuyasu RT; Fahey JL Nat Immun Cell Growth Regul; 1988; 7(1):13-30. PubMed ID: 2896298 [TBL] [Abstract][Full Text] [Related]
6. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells. Gaddy J; Broxmeyer HE Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743 [TBL] [Abstract][Full Text] [Related]
7. Development of natural killer cell function in the human fetus. Uksila J; Lassila O; Hirvonen T; Toivanen P J Immunol; 1983 Jan; 130(1):153-6. PubMed ID: 6847879 [TBL] [Abstract][Full Text] [Related]
8. Mode of in vitro augmentation of natural killer cell activity by recombinant human interleukin 2: a comparative study of Leu-11+ and Leu-11- cell populations in cord blood and adult peripheral blood. Seki H; Ueno Y; Taga K; Matsuda A; Miyawaki T; Taniguchi N J Immunol; 1985 Oct; 135(4):2351-6. PubMed ID: 3928745 [TBL] [Abstract][Full Text] [Related]
9. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells. Frey JR; Kamber M; Peck R Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569 [TBL] [Abstract][Full Text] [Related]
10. Modulation of in vitro porcine natural killer cell activity by recombinant interleukin-1 alpha, interleukin-2 and interleukin-4. Knoblock KF; Canning PC Immunology; 1992 Jun; 76(2):299-304. PubMed ID: 1634252 [TBL] [Abstract][Full Text] [Related]
11. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones. van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399 [TBL] [Abstract][Full Text] [Related]
12. Interplay in vitro between ACTH, beta-endorphin, and glucocorticoids in the modulation of spontaneous and lymphokine-inducible human natural killer (NK) cell activity. Gatti G; Masera RG; Pallavicini L; Sartori ML; Staurenghi A; Orlandi F; Angeli A Brain Behav Immun; 1993 Mar; 7(1):16-28. PubMed ID: 8386029 [TBL] [Abstract][Full Text] [Related]
13. Regulation of human natural killer cell activity by interferon-gamma: lack of a role in interleukin 2-mediated augmentation. Sayers TJ; Mason AT; Ortaldo JR J Immunol; 1986 Mar; 136(6):2176-80. PubMed ID: 3081640 [TBL] [Abstract][Full Text] [Related]
14. The different effects of recombinant human interferon-gamma and recombinant human interferon-beta on the activation of natural killer cells. Okabe M; Gomi K; Morimoto M; Nakamizo N Jpn J Cancer Res; 1985 Jul; 76(7):608-17. PubMed ID: 3928557 [TBL] [Abstract][Full Text] [Related]
15. [Ontogenic development of human natural killer (NK) cells and lymphokine activated killer (LAK) cells]. Saito S; Saito M; Moriyama I; Hino K; Ichijo M Nihon Sanka Fujinka Gakkai Zasshi; 1987 Apr; 39(4):591-8. PubMed ID: 3495618 [TBL] [Abstract][Full Text] [Related]
16. The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum. Webb BJ; Bochan MR; Montel A; Padilla LM; Brahmi Z Cell Immunol; 1994 Dec; 159(2):246-61. PubMed ID: 7994757 [TBL] [Abstract][Full Text] [Related]
17. Release of lymphokines after Epstein Barr virus infection in vitro. I. Sources of and kinetics of production of interferons and interleukins in normal humans. Lotz M; Tsoukas CD; Fong S; Dinarello CA; Carson DA; Vaughan JH J Immunol; 1986 May; 136(10):3636-42. PubMed ID: 3009608 [TBL] [Abstract][Full Text] [Related]
18. Natural killer cell function of human neonatal lymphocytes. Uksila J; Lassila O; Hirvonen T Clin Exp Immunol; 1982 Jun; 48(3):649-54. PubMed ID: 6180853 [TBL] [Abstract][Full Text] [Related]
19. Natural killer (NK) cells as a responder to interleukin 2 (IL 2). II. IL 2-induced interferon gamma production. Handa K; Suzuki R; Matsui H; Shimizu Y; Kumagai K J Immunol; 1983 Feb; 130(2):988-92. PubMed ID: 6294182 [TBL] [Abstract][Full Text] [Related]